Bacterial infections in cirrhosis

Liver International

Volumn 24, Issue 4, 2004, Pages 277-280

  Navasa, Miguel ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antibiotics; Arterial hypotension; Hepatorenal syndrome; Sepsis; Splanchnic vasodilatation; Spontaneous bacterial peritonitis

Indexed keywords

ALBUMIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFADROXIL; CEFONICID; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ASCITES FLUID; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IATROGENIC DISEASE; INTESTINE FLORA; LEUKOCYTE FUNCTION; LIVER CIRRHOSIS; NEPHROTOXICITY; NEUTROPHIL; NONHUMAN; PROBABILITY; RESPIRATORY TRACT INFECTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SUPERINFECTION; URINARY TRACT INFECTION;

EID: 4444242344     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0934.x     Document Type: Review

References (33)

1. Rimola A, Navasa M. Infections in liver disease. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J, eds. Oxford Textbook of Clinical Hepatology, 2nd edn. Oxford: Oxford University Press, 1999; 1861-76.
2. Guarner C, Runyon BA. Macrophage function in cirrhosis and the risk of bacterial infection. Hepatology 1995; 22: 367-9.
3. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8: 632-5.
4. Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16: 724-7.
5. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-53.
6. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985; 5: 457-62.
7. Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991; 100: 1737-42.
8. Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995; 21:674-9.
9. Mercader J, Gómez J, Ruiz J, et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 1989; 35(suppl 2): 23-6.
10. Gómez-Jimenez J, Ribera E, Gasser I, et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Ag Chemother 1993; 37: 1587-92.
11. Ariza J, Xiol X, Esteve M, et al. Aztreonam vs. Cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology 1991; 14: 91-8.
12. Grange JD, Amiot X, Grange V, et al. Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology 1990; 11: 360-4.
13. Ricart E, Soriano G, Novella M.T, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000; 32: 596-602.
14. Silvain C, Breux JP, Grollier G, et al. Les septicémies et les infections du liquide d'ascite du cirrhotique peuvent-elles ê tre traitées exclusivement par voie orale? Gastroenterol Clin Biol 1989; 13: 335-9.
15. Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996; 111: 1011-7.
16. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.
17. Ginès P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12: 716-24.
18. Llovet JM, Rodríguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol 1997; 26: 88-95.
19. Campillo B, Dupeyron C, Richardet J-P, et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998; 26: 1066-70.
20. Novella M, Solà R, Soriano G, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997; 25: 532-6.
21. Ortiz J, Vila MC, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999; 29: 1064-9.
22. Burroughs AK, Rosenstein IJ, Epstein O, et al. Gut 1984; 25: 133-7.
23. Lipsky B.A. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis and treatment. Ann Intern Med 1989; 110: 138-50.
24. Westphal J-F, Jehl F, Vetter D. Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver. Clin Infect Dis 1994; 18: 324-35.
25. Adams HG, Jordan C. Infections in the alcoholic. Med Clin N Am 1984; 68: 179-200.
26. Bradsher RW. Overwhelming pneumonia. Med Clin N Am 1983; 67: 1233-50.
27. Levy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Chest 1988; 92: 43-8.
28. Craven DE, Daschner F, Guiot L. Current topic: nosocomial pneumonia. Eur J Clin Infec Dis 1989; 8: 1-75.
29. Torres A, Celis R. Neumonías intrahospitalarias. Med Clin (Barc) 1987; 88: 34-7.
30. Swartz MN. Cellulitis and Superficial Infections. In: Mandel GL, Douglas RG JR., eds. Principles and Practice of Infectious Diseases, 3rd edn. New York: Churchill Livingstone, 1990; 796-807.
31. Snyder N, Atterbury CE, Correia JP, Conn HO. Increased ocurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. Gastroenterology 1977; 73: 1107-13.
32. Denton JH, Rubio C, Velázquez J, de Arellano GR. Bacterial endocarditis in cirrhosis. Dig Dis Sci 1981; 26: 935-7.
33. Flaum MA. Spontaneous bacterial empyema in cirrhosis. Gastroenterology 1976; 70: 416-7.